T2Evolve
  • Home
  • Concept
  • Consortium
  • Stakeholder Community
  • Resources
    • News & Events
    • Latest Tweets
    • Publications
    • Materials
  • Patient hub
  • Contact
Select Page
European patient survey on CAR T-cell therapy to gain insights into patients’ experiences, quality of life and unmet needs

European patient survey on CAR T-cell therapy to gain insights into patients’ experiences, quality of life and unmet needs

by Danny Liu | Jan 27, 2023 | Uncategorized

Also available in: Deutsch Français Español Nederlands Italiano Português After months of preparation and close collaboration with patient advocacy groups, patients and carers, the T2EVOLVE and QUALITOP consortia are proud to launch their European patient survey on...
Details about upcoming launch of the European Patient Survey on CAR T-cell therapy

Details about upcoming launch of the European Patient Survey on CAR T-cell therapy

by Danny Liu | Jan 12, 2023 | Uncategorized

Next week, the T2EVOLVE and QUALITOP consortia will launch a survey developed to understand, analyze and meet the needs of European patients treated with CAR-T therapy for hematological cancers. To reach and engage as many patients as possible, T2EVOLVE’s Work...

Happy holidays from everyone at T2EVOLVE

by Danny Liu | Dec 20, 2022 | Uncategorized

Join T2EVOLVE at the 5th European CAR T-cell meeting

Join T2EVOLVE at the 5th European CAR T-cell meeting

by Danny Liu | Nov 22, 2022 | Uncategorized

The 5th European CAR T-cell Meeting takes place in Rotterdam, the Netherlands, on February 9-11, 2023. The meeting is the largest CAR-T event in Europe in 2023. The previous edition of the meeting had more than 1.000 on-site participants and 120 abstracts. For the...
Hélène Negre and Michael Hudecek to speak at Onco Cell Therapy Summit Europe

Hélène Negre and Michael Hudecek to speak at Onco Cell Therapy Summit Europe

by Danny Liu | Oct 26, 2022 | Uncategorized

Hélène Negre, T2EVOLVE Project Leader, and Michael Hudecek, T2EVOLVE Project Coordinator, are speakers at the Onco Cell Therapy Summit Europe in Amsterdam on Thursday, November 3. Hélène will present the T2EVOLVE Consortium while Michael speaks about new targets and...
First face-to-face Strategic Consortium meeting takes place in Paris

First face-to-face Strategic Consortium meeting takes place in Paris

by Danny Liu | Oct 24, 2022 | Uncategorized

The first face-to-face T2EVOLVE Strategic Consortium meeting took place in Paris over the course of two days last week. It was a pleasure for our work package team leads and contributors and T2EVOLVE coordinators to finally meet in person and work together. We hope to...
« Older Entries
  • Cookie policy
  • Privacy Statement
  • Terms and Conditions
Proudly Developed and Designed by T2EVOLVE
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
Preferences
{title} {title} {title}